Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib in Children and Adolescents From 8 Years to Less Than 18 Years of Age With Polyarticular-course Juvenile Idiopathic Arthritis

NCT07554495 is registered in ClinicalTrials.gov with Alfasigma S.p.A. as lead sponsor.

NCT NCT07554495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07554495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib in Children and Adolescents From 8 Years to Less Than 18 Years of Age With Polyarticular-course Juvenile Idiopathic Arthritis
Lead sponsor
Alfasigma S.p.A.
Phase
Phase 3
Overall status
Recruiting
Start date
May 21, 2026
Completion date
June 30, 2027
Enrollment
65 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

polyarticular course juvenile idiopathic arthritis